Healthcare provider profile · identity verified

Manisha Singhi Garg, MD

Internal Medicine · DEARBORN, MI · NPI 1740288984

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	611	163
Levothyroxine Sodium	Levothyroxine Sodium	414	116
Amlodipine Besylate	Amlodipine Besylate	378	97
Losartan Potassium	Losartan Potassium	365	98
Metoprolol Succinate	Metoprolol Succinate	345	95
Simvastatin	Simvastatin	331	88
Rosuvastatin Calcium	Rosuvastatin Calcium	294	89
Lisinopril	Lisinopril	263	68
Omeprazole	Omeprazole	242	73
Alprazolam	Alprazolam	240	49
Metformin Hcl	Metformin Hcl	215	59
Pravastatin Sodium	Pravastatin Sodium	211	55
Pantoprazole Sodium	Pantoprazole Sodium	201	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	181	30
Fluticasone Propionate	Fluticasone Propionate	175	75
Alendronate Sodium	Alendronate Sodium	165	38
Eliquis	Apixaban	160	39
Escitalopram Oxalate	Escitalopram Oxalate	158	51
Tamsulosin Hcl	Tamsulosin Hcl	154	52
Metoprolol Tartrate	Metoprolol Tartrate	152	40
Furosemide	Furosemide	148	48
Trazodone Hcl	Trazodone Hcl	145	37
Famotidine	Famotidine	140	49
Tramadol Hcl	Tramadol Hcl	134	23
Gabapentin	Gabapentin	128	45
Duloxetine Hcl	Duloxetine Hcl	109	28
Ezetimibe	Ezetimibe	108	29
Jardiance	Empagliflozin	107	32
Glimepiride	Glimepiride	106	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	101	28
Montelukast Sodium	Montelukast Sodium	97	32
Synthroid	Levothyroxine Sodium	97	26
Sertraline Hcl	Sertraline Hcl	91	23
Clopidogrel	Clopidogrel Bisulfate	90	22
Potassium Chloride	Potassium Chloride	90	33
Albuterol Sulfate Hfa	Albuterol Sulfate	89	38
Meloxicam	Meloxicam	84	38
Zolpidem Tartrate	Zolpidem Tartrate	83	14
Cephalexin	Cephalexin	82	48
Metformin Hcl Er	Metformin Hcl	82	30
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	78	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	16
Allopurinol	Allopurinol	69	22
Carvedilol	Carvedilol	68	20
Hydrochlorothiazide	Hydrochlorothiazide	67	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	65	13
Januvia	Sitagliptin Phosphate	63	16
Ozempic	Semaglutide	60	12
Atenolol	Atenolol	52	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	14
Clonazepam	Clonazepam	51	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	48	48
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	13
Donepezil Hcl	Donepezil Hcl	45	13
Fenofibrate	Fenofibrate	45	11
Finasteride	Finasteride	45	13
Mounjaro	Tirzepatide	44	11
Methylprednisolone	Methylprednisolone	43	38
Bupropion Xl	Bupropion Hcl	42	11
Buspirone Hcl	Buspirone Hcl	42	suppressed
Prednisone	Prednisone	41	22
Clonidine Hcl	Clonidine Hcl	40	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	suppressed
Meclizine Hcl	Meclizine Hcl	37	19
Azithromycin	Azithromycin	36	33
Nystatin	Nystatin	33	20
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	23
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Linzess	Linaclotide	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Lansoprazole	Lansoprazole	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	25
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Valsartan	Valsartan	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Glyxambi	Empagliflozin/Linagliptin	26	suppressed
Repatha Sureclick	Evolocumab	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Bumetanide	Bumetanide	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Digoxin	Digoxin	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Mupirocin	Mupirocin	24	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	19
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Verapamil Hcl	Verapamil Hcl	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Oxazepam	Oxazepam	17	suppressed
Ramipril	Ramipril	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Topiramate	Topiramate	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Propranolol Hcl	Propranolol Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	11
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	11
Colchicine	Colchicine	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide	Glipizide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error